Raiffeisen Bank International »

Allogene Therapeutics shares owned by Raiffeisen Bank International

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Raiffeisen Bank International from 13F filings

Historical chart of Raiffeisen Bank International investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Raiffeisen Bank International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Raiffeisen Bank International

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.6M 702k 2.22

More positions owned by Raiffeisen Bank International

Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOGL)
Apple Common Stock (AAPL)
Broadcom Common Stock (AVGO)
Amazoncom Common Stock (AMZN)
Applied Materials Common Stock (AMAT)
Eli Lilly & Co Common Stock (LLY)
Lam Research Corp Common Stock (LRCX)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Jpmorgan Chase & Co Common Stock (JPM)
Cisco Systems Common Stock (CSCO)
Abbvie Common Stock (ABBV)
Visa Common Stock (V)
Quanta Services Common Stock (PWR)
Advanced Micro Devices Common Stock (AMD)

View all positions for Raiffeisen Bank International

Top funds holding Allogene Therapeutics

Pfizer
BlackRock
Tpg Gp A
Vanguard Group
State Street Corporation
PRIMECAP Management Company
Vanguard Capital Management
Citadel Advisors
Two Sigma Investments
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Patient Square Capital
Marshall Wace
Millennium Management

View all funds holding Allogene Therapeutics